Abstract

In April 2017, the Scottish Medicine Consortium approved emtricitabine/tenofovir disoproxil for use as HIV pre-exposure prophylaxis (PrEP), in combination with safer sex practices.1 National Health Service (NHS) Greater Glasgow and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call